A20 inhibits CRC progression by reducing the activation of ERK and P38 signaling pathways and by mitigating TNFα‐induced chemokine production, thus controlling inflammation and oncogenic signaling.311. Here, TNFAIP3 is linked to colorectal carcinoma.